XTX Topco Ltd Acquires 19,886 Shares of Oscar Health, Inc. (NYSE:OSCR)

XTX Topco Ltd boosted its holdings in Oscar Health, Inc. (NYSE:OSCR) by 42.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 66,930 shares of the company’s stock after purchasing an additional 19,886 shares during the period. XTX Topco Ltd’s holdings in Oscar Health were worth $1,059,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in OSCR. Avalon Trust Co bought a new stake in Oscar Health in the first quarter worth $69,000. Prevail Innovative Wealth Advisors LLC bought a new stake in Oscar Health in the fourth quarter worth $92,000. Quest Partners LLC bought a new stake in Oscar Health in the second quarter worth $93,000. Amalgamated Bank lifted its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Focus Financial Network Inc. ADV bought a new stake in Oscar Health in the fourth quarter worth $152,000. 75.70% of the stock is owned by institutional investors.

Insider Activity at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock worth $3,007,069 over the last 90 days. 25.11% of the stock is owned by company insiders.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $22.93 on Friday. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The company’s 50-day moving average is $17.90 and its 200 day moving average is $17.55. The stock has a market capitalization of $5.55 billion, a P/E ratio of -57.32, a P/E/G ratio of 43.42 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the previous year, the company earned ($0.07) earnings per share. Oscar Health’s quarterly revenue was up 44.6% on a year-over-year basis. On average, sell-side analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have weighed in on OSCR shares. Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Wells Fargo & Company upped their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Robert W. Baird initiated coverage on shares of Oscar Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $28.00 price objective for the company. Bank of America reaffirmed a “neutral” rating and set a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Finally, Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.17.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.